From 2020 to 2025, prior authorization for #GLP1-RAs became near-universal and OOP costs rose substantially in 2025, as plans increasingly required coinsurance.
ja.ma/3Vx5tRi
@mfurlano.bsky.social
Nephrologist, Inherited kidney diseases working group, Rare kidney diseases, #GTERH @senefrologia.bsky.social
From 2020 to 2025, prior authorization for #GLP1-RAs became near-universal and OOP costs rose substantially in 2025, as plans increasingly required coinsurance.
ja.ma/3Vx5tRi
🧬 No has podido estar en las jornadas anuales del #GTERH?
🧬 Has ido y quieres repasar conceptos?
🧬Acabas de hacer el #MIR2025 y tienes dudas de qué especialidad escoger?
👇🏻Ya están disponibles los vídeos de las jornadas 2025👇🏻💖
#geneticarenal #mir25 #nefrologia
www.senefro.org/modules.php?...
The proof is in the data: academic.oup.com/ndt/advance-...
Cysts are not caused by Alport syndrome, though patients with Alport syndrome can have cysts.
2️⃣ We used microscopic haematuria as an early flag, reaching out to families and offering genomic testing. Five kids + two family members diagnosed with Alport syndrome! 🩺 link.springer.com/article/10.1...
17.02.2025 21:05 — 👍 8 🔁 2 💬 1 📌 0Genotype and X-chromosome inactivation are associated with disease severity in females with X-linked Alport syndrome
doi.org/10.1093/ndt/...
COL4A5 Intronic Variants at Third to Fifth Nucleotides Cause Alport Syndrome pubmed.ncbi.nlm.nih.gov/39990911/
03.03.2025 17:42 — 👍 24 🔁 14 💬 0 📌 0-165 patients with #Alport syndrome enrolled
-Median duration of follow up was 90 weeks
-Sponsored by Regulus Therapeutics/Sanofi
-Results will be very useful for designing future interventional trials
Prospective Cohort Study in #Alport Syndrome Patients under Standard Therapy - the ATHENA study www.kireports.org/article/S246...
08.03.2025 16:08 — 👍 28 🔁 9 💬 1 📌 2Cover of the March issue of Nature Reviews Nephrology
In our March issue: Reviews on integrins, endothelin-receptor antagonists, tubule–glomerulus crosstalk and collagens, plus Comments for #WorldKidneyDay on CKD screening, awareness, risk factors and AI-assisted detection go.nature.com/419A0GY
20.02.2025 10:20 — 👍 9 🔁 3 💬 0 📌 0Clinical Spectrum and Prognosis of Atypical ADPKD Caused by Monoallelic Pathogenic Variants of IFT140
https://bit.ly/4h1uEDV
#VisualAbstract
On International Women’s Day, as the first woman president of @ERAkidney, I dream of a future where we no longer need to say ‘first woman’ for any role or position.
08.03.2025 18:29 — 👍 7 🔁 3 💬 0 📌 0🧬#Alportsyndrome
The #ATHENA trial results showed:
- UACR and UPCR correlate best with eGFR decline
- identified other potential biomarkers that may serve as predictors of eGFR decline
@senefrologia.bsky.social #GTERH
👇🏻
Check this nice review about Extrarenal manifestations in inherited kidney diseases @ndt-era.bsky.social #nephsky
academic.oup.com/ndt/article/...
This initiative urges action to:
🔹 Improve global access to kidney care
🔹 Raise awareness of kidney health
🔹 Address environmental risks
🔹 Prioritize kidney diseases within the NCD agenda for stronger prevention and care.
more external validation of the anti-nephrin story
academic.oup.com/ckj/advance-... in @ckj-era.bsky.social
In around 20% MCD - but also some FSGS (suggesting again these arbitrary pathologic descriptors are not useful)
#NephSky
4️⃣ The KDIGO ADPKD Guideline offers a roadmap for evidence-based care, aiming to reduce the global burden of this inherited condition and improve lives worldwide.
Download the ADPKD Guideline, Executive Summary, and Data Supplement: kdigo.co/ADPKD
Read the guideline in KI: kdigo.co/ADPKD-Guidel...
1️⃣ We are pleased to announce the publication of the KDIGO 2025 ADPKD Guideline!
This first-ever KDIGO guideline focused on a rare kidney disease provides practical tools to improve diagnosis, care, and treatment.
Read the news release: kdigo.co/2025-ADPKD-G...
#ADPKD
Do you remember #TopNephrology stories in 2023? 👇Here is the recap
💡 #NephSky #MedSky any proposals for 2024?
www.nephjc.com/news/2024/1/...
🧬Muchas gracias Dra Paula Gandía del Hospital Peset de Valencia y Dra Andreia Gaspar Carnevale del Hospital Santa Cruz de #Lisboa por haber venido a formarse en enfermedades hereditarias en #ERH 🧬
29.11.2024 14:52 — 👍 4 🔁 0 💬 0 📌 0🧬Estudio de nefropatía por HNF1B en España #enfermedadesraras
#minoritarias
➡️ Instrucciones para participar en la web de @senefrologia.bsky.social en la parte del #GTERH
🙋♀️IP: Beatriz Redondo
👇🏻 senefro.org/modules.php?...
🆕 Antibody identified in podocytopathies 🫘after Anti nephrin Ab⭐
Anti Slit diaphragm Ab ‼️‼️‼️
The heterogeneity in response to immunosuppression is understandable now!
#Nephsky
Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease @natureportfolio.bsky.social 👩🔬🧪🥼👨🔬 #Nephropathy ##NephSky #kidney #Kidneydisease #inflammation #fibrosis #nephrology ##cardiosky 👇👇
www.nature.com/articles/s41...
🧬Formación en enfermedades renales hereditarias 🧬
➡️En la web de @senefrologia.bsky.social en la parte del #GTERH, están todos los vídeos de las charlas de las jornadas de marzo de 2024 y anteriores
✅ un recurso para explorar y estar actualizados en #ERH 🧬👇🏻
senefro.org/modules.php?na…
Our spotlight on collagen- formation, function & role in kidney disease is out now!
A wonderful collaboration with Moumita Barua & Vanessa De Gregorio
#ECMatrix
#Nephro
Cell-Matrix Centre
@fbmh-uom.bsky.social
@uoft.bsky.social
www.nature.com/articles/s41...
💯Approach to elevated Ferritin
Infographic @bmj.com
HUS has a poor prognosis in children receiving maintenance kidney replacement therapy. Read this Original Article on HUS as cause of CKD stage 5 in children: results from the Polish Registry of Kidney Replacement Therapy in children. #OpenAccess
link.springer.com/article/10.100…
🧬Genetic testing in nephrology🧬
18.11.2024 08:31 — 👍 1 🔁 2 💬 0 📌 0